RDCURE Trademark

Trademark Overview

On Wednesday, January 12, 2022, a trademark application was filed for RDCURE with the United States Patent and Trademark Office. The USPTO has given the RDCURE trademark a serial number of 97215495. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Tuesday, March 4, 2025. This trademark is owned by RDCure LLC. The RDCURE trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Providing information relating to pharmaceuticals and gene therapies; Pharmaceutical advice; Providing medical advice in the field of gene therapy; Pharmaceutical and gene therapy consultation
rdcure

General Information

Serial Number97215495
Word MarkRDCURE
Filing DateWednesday, January 12, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateTuesday, March 4, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Pseudo MarkRD CURE
Goods and ServicesProviding information relating to pharmaceuticals and gene therapies; Pharmaceutical advice; Providing medical advice in the field of gene therapy; Pharmaceutical and gene therapy consultation

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, January 19, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRDCure LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPhiladelphia, PA 19125
Party NameRDCure LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPhiladelphia, PA 19125

Trademark Events

Event DateEvent Description
Saturday, January 15, 2022NEW APPLICATION ENTERED
Wednesday, January 19, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, October 19, 2022ASSIGNED TO EXAMINER
Thursday, October 20, 2022NON-FINAL ACTION WRITTEN
Thursday, October 20, 2022NON-FINAL ACTION E-MAILED
Thursday, October 20, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, April 20, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, April 20, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 20, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, June 5, 2023EXAMINERS AMENDMENT -WRITTEN
Monday, June 5, 2023EXAMINERS AMENDMENT E-MAILED
Monday, June 5, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, June 5, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, June 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 12, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Saturday, February 24, 2024SOU TEAS EXTENSION RECEIVED
Saturday, February 24, 2024SOU EXTENSION 1 FILED
Saturday, February 24, 2024SOU EXTENSION 1 GRANTED
Monday, September 9, 2024SOU EXTENSION 2 FILED
Tuesday, February 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU TEAS EXTENSION RECEIVED
Monday, September 9, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, September 9, 2024SOU EXTENSION 2 GRANTED
Tuesday, March 4, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025SOU EXTENSION 3 FILED
Tuesday, March 4, 2025SOU EXTENSION 3 GRANTED
Wednesday, March 5, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

rdcure gene pharmaceutical therapy advice providing field consultation medical therapies information